Professor Ian Wilkinson
My research interest centres on the physiology and pharmacology of the cardiovascular system, and particularly hypertension, the large arteries and endothelial function. Current research projects include investigating the effect of ageing on the cardiovascular system, the link between inflammation and arterial function, and the effect of novel nitric oxide donors on pre-eclampsia. I am also involved in a number of large collaborative studies including CLEAREST Study, the Caerphilly Heart Study, ENIGMA Study and Whitehall II. In addition to my role with the OTR I am also the Director of the Cambridge University Health Partners Clinical Trials Unit, which works with principal investigators to develop and deliver world class clinical trials of all phases.
Dr Anita Marguerie de Rotrou
With a PhD in developmental biology (UCL), a postdoc at Cancer Research UK, experience in cell biology and several years in the regenerative field, I have worked on numerous projects in biotech companies at the operational, management and scientific levels. My expertise includes: setting up labs, teams and operations from scratch, technology transfer and exploitation, product development, production and drug discovery. In addition, I have experience helping companies and academics raise appropriate funding from the EU, government, and private sectors.
I joined the OTR at the University of Cambridge in 2015 and been appointed as the Head of the office two years later. Our mission is to translate basic science to clinical trial or commercialisation. To this end, we facilitate collaborations by building trust, understanding the concerns and motivations of those involved, along with finding potential areas of collaboration and building partnerships between industry and academia. The OTR progresses a portfolio of projects along the pipeline with the right input (expert advice, funding, regulatory) at the right time.
Contact: email@example.com; Tel: 01223 335650
Ms Tiiu Sildva
Translational Research Project Manager
I joined the OTR in June 2018 as a project manager for AIM HY INFORM, which is a multi-arm study with the aim of determining whether responses to mono or dual therapies among people with hypertension differ by self-defined ethnicity. I also work part-time as Programme Manager for the CRUK Urological Malignancies Programme.
As a registered nurse with a master of public health, I have worked in clinical and non-clinical public health environments across Australia, Canada and the UK since 2008, including leading health promotion projects in hard-to-reach indigenous communities. I’ve held diverse roles in medical-surgical nursing, teaching, project management, and international engagement, and contributed to WHO publications and best practice guideline development at the Registered Nurses’ Association of Ontario. Previously in the Department of Public Health & Primary Care (2014), I supported epidemiological chronic disease studies with their documentation (ethics applications, protocols, SOPs etc.), and logistics between medical device companies and collaborators in Sub-Saharan Africa. I am interested in promoting personalised medicine through translational research for better patient outcomes.
Contact: firstname.lastname@example.org; Tel: 01223 336934
Dr Estelle Bernard – Fichet
Translational Research Programme Manager
After being awarded a PhD in Electrochemistry applied to Biotechnology from UCL and a post-doctoral position at the former Institute of Biotechnology at the University of Cambridge, I gained a 10-year strong experience in MedTech industry. I worked in two multinationals companies: Unipath Ltd. (now SPD Swiss Precision Diagnostics GmbH) and Philips Corporate Innovation. My work extended across a variety of functions in R&D from science-based innovation ideation to proof of concept product. In particular, I worked in developing innovative diagnostics tools for women’s health, cardiac, sleep and oral healthcare applications. I am also experienced in understanding market needs and running clinical trials for medical devices.
I joined the Office of Translation Research in April 2018 as a Programme Manager. My role is to support University and NHS scientists translating their innovation in biomedical science into healthcare applications through structuring and managing both collaborative projects with industry and publicly funded translational research projects.
Contact: email@example.com; Tel: 01223 760004
Dr Alex Samoshkin
Translational Technology Manager
I am an experienced scientist with a strong background in biochemistry and genetics; I have been a Lecturer in the Faculty of Medicine at McGill University (Montreal, Canada) after working in multiple different world class biomedical research laboratories in cancer (NICHD and NCI, NIH, USA), neuroscience biology (UNC, Chapel Hill, USA) and cell biology (Institute of Cytology RAS, Russia where I obtained my PhD in 2006). I have extensive experience working with academic scientists and biotech companies, setting up labs and a core facility.
I joined the OTR in 2017; I am currently managing translational research activities within the Cambridge University Health Partners initiative and with industrial partners.
Contact: firstname.lastname@example.org; Tel: 01223 336802
Dr Nicola White
Translational Research Facilitator
Through previous roles, I have gained first-hand experience of working closely with academia and industry. Building on my doctoral and postdoctoral research in molecular genetics, I worked for GSK in discovery research focusing on the identification of susceptibility genes for complex diseases. Subsequently, as a lecturer at Cranfield University, I gained valuable experience of working with professional partners in the development, management and delivery of applied research projects and postgraduate executive education. During this time, collaborators included leading global pharmaceutical and medical device companies as well as charities and the NHS.
Within the OTR, I am a programme manager for the Experimental Medicine Training Initiative (EMI). This programme aims to address the translational research gap by supporting clinicians and non-clinician scientists in the development of essential knowledge and skills to lead future Experimental Medicine studies. The EMI is supported by the University of Cambridge in partnership with the Cambridge University Hospitals, NIHR Cambridge Biomedical Research Centre and industry partners AstraZeneca/MedImmune and GSK.
Contact: email@example.com; Tel 01223 748089
Ms Ewa Czekaj
As the office administrator I provide daily administrational support for all members of the office, manage the OTR’s website as well as take care of the logistics for a portfolio of projects run in the OTR. I am also responsible for organising meetings and arranging events related to industry and academic collaborations.
In addition, I work closely with Dr Sile Griffin in managing the AIM HY Consortium. My responsibilities here include administrational support as well as development and management of the AIM HY website.
Contact: firstname.lastname@example.org; Tel: 01223 760734
Office for Translational Research Postal Address
School of Clinical Medicine
University of Cambridge
Box 111 Cambridge Biomedical Campus
Cambridge CB2 0SP